PCI Biotech AS

https://www.pcibiotech.com

PCI Biotech is a biopharmaceutical company focusing on development and commercialisation of novel therapies for the treatment of cancer through its innovative photochemical internalisation (PCI) technology platform. PCI is applied to three distinct anticancer paradigms: fimaChem (enhancement of chemotherapeutics for localised treatment of cancer), fimaVacc (T-cell induction technology for therapeutic vaccination), and fimaNAc (nucleic acid therapeutics delivery). Photochemical internalisation induces triggered endosomal release that is used to unlock the true potential of a wide array of therapeutic modalities. The company's lead fimaChem programme consists of a clinical Phase I/II clinical study in bile duct cancer, an orphan indication with a high unmet need and without approved products. fimaVacc applies a unique mode of action to enhance the essential cytotoxic effect of therapeutic cancer vaccines, which works in synergy with several other state-of-the-art vaccination technologies. fimaNAc utilises the endosomal release to provide intracellular delivery of nucleic acids, such as mRNA and RNAi therapeutics, thereby addressing one of the major bottlenecks facing this emerging and promising field. *

	Start	2008-01-01 existent
	Group	PCI Biotech (Group)
	Industry	cancer drug
	Industry 2	cancer vaccine
	Person	Walday, Per (PCI Biotech 201503 CEO)

	Region	Oslo
	Country	Norway
	Street	64 Ullernchausséen
	City	0379 Oslo
	Tel	+47-67-115400
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: PCI Biotech Holding ASA. (8/23/17). "Press Release: PCI Biotech Appoints Dr Hans Olivecrona as Chief Medical Officer". Oslo.

		Record changed: 2024-02-12

Picture Berlin Partner Top News Healthtech Company Mika 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]